Nigel Hussain

538 total citations
24 papers, 402 citations indexed

About

Nigel Hussain is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Nigel Hussain has authored 24 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 12 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Nigel Hussain's work include Asymmetric Synthesis and Catalysis (9 papers), Chemical Synthesis and Analysis (7 papers) and Microbial Natural Products and Biosynthesis (5 papers). Nigel Hussain is often cited by papers focused on Asymmetric Synthesis and Catalysis (9 papers), Chemical Synthesis and Analysis (7 papers) and Microbial Natural Products and Biosynthesis (5 papers). Nigel Hussain collaborates with scholars based in United Kingdom and United States. Nigel Hussain's co-authors include Matthew G. Unthank, Varinder K. Aggarwal, John Leonard, James A. Wilkinson, David O. Morgan, Sylvie Ducki, Richard K. Bellingham, John Carey, P. Oxley and Richard J. Atkins and has published in prestigious journals such as Angewandte Chemie International Edition, Tetrahedron and European Journal of Pharmacology.

In The Last Decade

Nigel Hussain

24 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nigel Hussain United Kingdom 11 357 81 56 23 18 24 402
Anyu He United States 12 412 1.2× 84 1.0× 106 1.9× 25 1.1× 14 0.8× 17 446
Geanna K. Min Denmark 9 408 1.1× 82 1.0× 79 1.4× 22 1.0× 12 0.7× 11 438
Kazato Inanaga Japan 11 413 1.2× 68 0.8× 61 1.1× 16 0.7× 17 0.9× 13 426
Irina K. Sagamanova United States 9 543 1.5× 81 1.0× 67 1.2× 18 0.8× 12 0.7× 15 583
Zhonghui Wan United States 9 471 1.3× 101 1.2× 78 1.4× 23 1.0× 7 0.4× 10 517
Matthew J. Fleming Canada 12 356 1.0× 58 0.7× 108 1.9× 26 1.1× 13 0.7× 12 384
Darren Stead United Kingdom 10 527 1.5× 132 1.6× 107 1.9× 18 0.8× 11 0.6× 18 587
Jack Melton Germany 5 367 1.0× 126 1.6× 47 0.8× 27 1.2× 24 1.3× 7 445
Viatcheslav Stepanenko Puerto Rico 11 285 0.8× 166 2.0× 121 2.2× 14 0.6× 25 1.4× 24 349
David Lathbury United Kingdom 14 539 1.5× 99 1.2× 96 1.7× 22 1.0× 21 1.2× 27 571

Countries citing papers authored by Nigel Hussain

Since Specialization
Citations

This map shows the geographic impact of Nigel Hussain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel Hussain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel Hussain more than expected).

Fields of papers citing papers by Nigel Hussain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel Hussain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel Hussain. The network helps show where Nigel Hussain may publish in the future.

Co-authorship network of co-authors of Nigel Hussain

This figure shows the co-authorship network connecting the top 25 collaborators of Nigel Hussain. A scholar is included among the top collaborators of Nigel Hussain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel Hussain. Nigel Hussain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilkinson, James A., et al.. (2007). 2′-Hydroxy-fendiline analogues as potent relaxers of isolated arteries. European Journal of Pharmacology. 561(1-3). 160–163. 5 indexed citations
2.
Carey, John, et al.. (2007). Large-Scale Preparation of 2-Methyloxazole-4-carboxaldehyde. Organic Process Research & Development. 12(1). 88–95. 11 indexed citations
3.
Wilkinson, James A., et al.. (2007). Synthesis and Evaluation of 2-Substituted Fendiline Analogues as Antileukemics. Letters in Drug Design & Discovery. 4(4). 246–248. 1 indexed citations
4.
Unthank, Matthew G., Nigel Hussain, & Varinder K. Aggarwal. (2006). The Use of Vinyl Sulfonium Salts in the Stereocontrolled Asymmetric Synthesis of Epoxide‐ and Aziridine‐Fused Heterocycles: Application to the Synthesis of (−)‐Balanol. Angewandte Chemie International Edition. 45(42). 7066–7069. 129 indexed citations
5.
Wilkinson, James A., et al.. (2005). Asymmetric alkylation of diarylmethane derivatives. Tetrahedron. 62(8). 1833–1844. 50 indexed citations
6.
Bellingham, Richard K., et al.. (2004). A Practical Synthesis of a Potent δ-Opioid Antagonist:  Use of a Modified Knorr Pyrrole Synthesis. Organic Process Research & Development. 8(2). 279–282. 17 indexed citations
7.
Wilkinson, James A., et al.. (2004). Asymmetric alkylation of N-pivaloyl-o-benzylaniline. Tetrahedron Asymmetry. 15(19). 3011–3013. 16 indexed citations
8.
Atkins, Richard J., Richard K. Bellingham, John Carey, et al.. (2003). The Development of a Manufacturing Route for the GPIIb/IIIa Receptor Antagonist SB-214857-A. Part 2:  Conversion of the Key Intermediate SB-235349 to SB-214857-A. Organic Process Research & Development. 7(5). 663–675. 28 indexed citations
9.
Andrews, Ian P., Richard J. Atkins, Neil F. Badham, et al.. (2001). A new synthesis of the GPIIb/IIIa receptor antagonist SB-214857-A. Tetrahedron Letters. 42(29). 4915–4917. 19 indexed citations
10.
Malkov, Andrei V., et al.. (2001). Molybdenum-Catalyzed Allylic Substitution in Glycals: A C-C Bond-Forming Ferrier-Type Reaction. Collection of Czechoslovak Chemical Communications. 66(12). 1735–1745. 6 indexed citations
11.
Karl, W., Richard K. Bellingham, David S. Ennis, et al.. (2001). Development of an Efficient and Stereoselective Manufacturing Route to Idoxifene. Organic Process Research & Development. 5(5). 479–490. 14 indexed citations
12.
Andrews, Ian P., Timothy S. Harvey, Nigel Hussain, et al.. (1996). A practical synthesis of the milbemycin SB-201561. Tetrahedron Letters. 37(27). 4811–4814. 5 indexed citations
13.
Hussain, Nigel & David O. Morgan. (1995). A mild and efficient method for the formation of a key intermediate in penem chemistry. Tetrahedron Letters. 36(25). 4487–4488. 4 indexed citations
14.
Hussain, Nigel, et al.. (1995). Synthesis of an α-(aminooxy)arylacetic ester by the reaction of an α-diazo ester with n-hydroxyphthalimide. Tetrahedron Letters. 36(44). 8141–8144. 6 indexed citations
15.
Hussain, Nigel, et al.. (1994). Semi-synthetic C23-substituted milbemycins via spiroacetal cleavage and resynthesis. Tetrahedron Letters. 35(15). 2385–2388. 4 indexed citations
16.
Leonard, John & Nigel Hussain. (1994). Total synthesis of (±)-specionin. Journal of the Chemical Society Perkin Transactions 1. 61–70. 2 indexed citations
17.
Hussain, Nigel, et al.. (1994). Spiroacetal synthesis from a key lactone intermediate leading to novel C24 and C25-substituted milbemycins. Tetrahedron Letters. 35(15). 2381–2384. 7 indexed citations
18.
Leonard, John & Nigel Hussain. (1994). Studies on the functionalisation of cis-bicyclo[3.3.0]oct-7-en-2-ol—approaches to the synthesis of specionin. Journal of the Chemical Society Perkin Transactions 1. 49–60. 2 indexed citations
19.
Hussain, Nigel, et al.. (1994). Fragmentations and rearrangements of 22-hydroxyl substituted milbemycins - synthesis of a key lactone intermediate. Tetrahedron Letters. 35(15). 2377–2380. 3 indexed citations
20.
Hussain, Nigel & John Leonard. (1987). Total synthesis of specionin - natural product or artifact ?. Tetrahedron Letters. 28(41). 4871–4874. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026